Articles by Eduardo Franco, MD

• 

  News
  ASH 2023: On the Way to Improved Treatment for Newly Diagnosed Follicular Lymphoma with Acalabrutinib Added to Lenalidomide and Rituximab
  Dec 12, 2023
• 

  News
  Ensayo Clínico: Usar Iberdomida Sola o Con Dexametasona en el Mieloma Latente
  Oct 31, 2023
• 

  News
  The Innovation of Myeloma in the 2000s and 2010s
  Sep 20, 2023
• 

  News
  ASCO 2023: The Ground-Breaking Combination of Two Bi-specific Antibody Therapies
  Jun 07, 2023
• 

  News
  Clinical Trial: Better Imaging to Track Myeloma Precursor Condition Bone Damage
  Apr 06, 2023
• 

  News
  Biopsy Location Matters When it Comes to Evaluating Myeloma Genetics
  Mar 07, 2023
• 

  News
  Clinical Trial: Iberdomide Alone or With Dexamethasone in Smoldering Myeloma
  Nov 03, 2022
• 

  News
  An Off-the-Shelf CAR T Clinical Trial for Relapsed or Refractory Myeloma Patients (ALLO-715)
  Sep 08, 2022
• 

  News
  The Regeneron Bispecific Antibody for Multiple Myeloma
  Feb 15, 2022